SCHEMBL19734616

SCHEMBL19734616

COc1cc(C(O)C(O)c2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
HPGD P15428 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
F2 P00734 1/20 0.53
F10 P00742 1/20 0.53
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
F7 P08709 1/20 0.53
F3 P13726 1/20 0.53
PRSS3 P35030 1/20 0.53
PPARG P37231 1/20 0.53
PPARD Q03181 1/20 0.53
PPARA Q07869 1/20 0.53
CTSV O60911 2/20 0.51
CTSL P07711 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9586284 0.94 SMPD1 (0.56) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL19738141 0.93 NPC1 (0.56) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL19728203 0.92 NPC1 (0.50) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL14168120 0.91 NPC1 (0.57) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL7048118 0.88 NPC1 (0.54) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL12738664 0.86 NPC1 (0.55) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL14242938 0.86 NPC1 (0.52) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL5377231 0.85 HPGD (0.52) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL19628282 0.85 PPARG (0.51) NPC1RAB9AHPGDSMN1; SMN2MEN1
SCHEMBL2060104 0.85 SMPD1 (0.56) NPC1RAB9AHPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362152-A1 NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF L'OREAL (FR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362152-A1 NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF GLA, DSG1, GPX1 NPC1 1482/4885RAB9A 3090/4885HPGD 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.